Overview
The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.
Description
This is a randomized, controlled trial to investigate if a structured exercise regimen will have benefit relative to the control arm by increasing and /or maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment as measured by 6-Minute Walk test and BOT-2 Brief or PDMS-2.
Eligibility
Inclusion Criteria:
- Ages 2-25 at time of consent
- Subject has newly diagnosed cancer per Investigator, and is planning to undergo chemotherapy for treatment of malignancy
- Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language
- Subject is anticipated to receive at least 3 months of chemotherapy or other cancer treatment.
- As determined and documented by the enrolling investigator, ability of the subject to understand and comply with study procedures for the entire length of the study
Exclusion Criteria:
- Known cardiac dysfunction that, in the opinion of the investigator, would be unsafe for the child to participate in the exercise program
- Recent (within 4 weeks of enrollment) or planned surgery that will result in prolonged limited mobility not amendable to exercise modifications per investigator discretion
- Primary CNS Tumor
- Osteosarcoma